New Zealand - English - Medsafe (Medicines Safety Authority)

apotex nz ltd - linezolid 600mg - film coated tablet - 600 mg - active: linezolid 600mg excipient: colloidal silicon dioxide crospovidone hyprolose hypromellose macrogol 8000 magnesium stearate methylcellulose titanium dioxide - linezolid apotex is indicated for the treatment of infections when known or suspected to be caused by susceptible organisms including those associated with concurrent bacteraemia such as: · pneumonia - community acquired and nosocomial pneumonia · skin and soft tissue infections · enterococcal infections. linezolid is active against gram-positive bacteria only. linezolid has no clinical activity against gram-negative pathogens. specific gram-negative therapy is required if a concomitant gram-negative pathogen is documented or suspected. consideration should be given to official guidance on the appropriate use of antibacterial agents.

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - montelukast sodium -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - mycophenolate mofetil -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - olanzapine -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - olanzapine -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - olanzapine -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - olanzapine -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - olanzapine -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - olanzapine -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - montelukast sodium -